Impact of margin status on outcomes after endoscopic resection of well-differentiated duodenal neuroendocrine tumors

Post written by Shruti Mony, MD, from the Department of Gastroenterology, Johns Hopkins University, Baltimore, Maryland, USA. The focus of our study was to assess the recurrence patterns after endoscopic resection of nonampullary duodenal neuroendocrine tumors [DNETs]. Specifically, we wanted to identify the risk factors, effect of positive histologic margins, and optimal surveillance strategies including …

Continue reading Impact of margin status on outcomes after endoscopic resection of well-differentiated duodenal neuroendocrine tumors

EUS diagnosis of cystic pancreatic neuroendocrine tumors

Post written by Harry R. Aslanian, MD, from the Section of Digestive Disease, Yale New Haven Medical Center, School of Medicine, New Haven, Connecticut, USA. We present a series of cases highlighting the EUS features of cystic pancreatic neuroendocrine tumors. Pancreas neuroendocrine tumors are rare and are less commonly cystic. The recognition and targeting of wall …

Continue reading EUS diagnosis of cystic pancreatic neuroendocrine tumors